Literature DB >> 3242446

Pharmacokinetics and biological activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin. 1. Dose-dependent tissue distribution and induction of hepatic ethoxyresorufin O-deethylase in rats following a single injection.

K Abraham1, R Krowke, D Neubert.   

Abstract

Concentrations of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in rat liver and adipose tissue, and hepatic ethoxyresorufin O-deethylase (EROD) activity were studied subsequent to a single subcutaneous injection of TCDD. Two types of experiments were performed to study: (a) time-dependent changes following a single injection of 300 ng TCDD/kg body wt (points 1-4), and (b) dose-dependent changes measurable after 7 days following a single injection (points 5-7). 1. Absorption of TCDD following a single subcutaneous injection was about 90% after 3 days and 98% after 5 days. 2. Following a single dose of 300 ng TCDD/kg body wt peak concentrations were: liver (after 3 days): 4.7 +/- 0.9 ng/g wet wt, and adipose tissue (after 7 days): 0.82 +/- 0.07 ng/g wet wt. 3. T1/2 of TCDD in liver was 13.6 days over the total experimental period (from day 10 to 91 of the study), apparently with an initial faster phase: 11.5 days (from day 10 to 49), and a slower period at the end of the experiment: 16.9 days (from day 49 to 91); in adipose tissue the t1/2 was 24.5 days (from day 14 to 91 of the study). 4. Maximum induction of EROD in the liver was observed (14-fold at 300 ng TCDD/kg body wt) 3-7 days following the injection; the activity was decreased to about one third of the maximum 3 weeks after the injection; increase in total cytochrome P-450 at this dose was only about 1.4-fold at the induction maximum. 5. The ratio of the TCDD concentrations in liver and adipose tissue increased considerably between doses of 3 ng TCDD/kg body wt (ratio: about 0.74) and 3000 ng TCDD/kg body wt (ratio: about 7.7). 6. The extent of EROD induction in the liver increased dose dependently. A significant effect was first observed with a dose of 3 ng TCDD/kg body wt (activity about +32% above control activity). The corresponding tissue concentration was about 10 pg TCDD/g liver wet wt. 7. An almost perfect linear relationship exists (when using a double-log plot) between the hepatic TCDD concentration and the EROD activity for tissue concentrations ranging from 40 to 30,000 pg TCDD/g wet wt.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3242446     DOI: 10.1007/bf00293624

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  24 in total

1.  Tissue distribution, excretion and biological effects of [14C]tetrachlorodibenzo-p-dioxin in rats.

Authors:  J R Allen; J P Van Miller; D H Norback
Journal:  Food Cosmet Toxicol       Date:  1975-10

2.  Quantitative determination of cytochrome P-450 in rat liver homogenate.

Authors:  T Matsubara; M Koike; A Touchi; Y Tochino; K Sugeno
Journal:  Anal Biochem       Date:  1976-10       Impact factor: 3.365

3.  Organ specific induction of drug metabolizing enzymes by 2,3,7,8-tetrachlorodibenzo-p-dioxin in the rat.

Authors:  A Aitio; M G Parkki
Journal:  Toxicol Appl Pharmacol       Date:  1978-04       Impact factor: 4.219

4.  Influence of solvents and adsorbents on dermal and intestinal absorption of TCDD.

Authors:  H Poiger; C Schlatter
Journal:  Food Cosmet Toxicol       Date:  1980-10

5.  Ethoxyresorufin: direct fluorimetric assay of a microsomal O-dealkylation which is preferentially inducible by 3-methylcholanthrene.

Authors:  M D Burke; R T Mayer
Journal:  Drug Metab Dispos       Date:  1974 Nov-Dec       Impact factor: 3.922

6.  Regulatory gene product of the Ah locus. Characterization of the cytosolic inducer-receptor complex and evidence for its nuclear translocation.

Authors:  A B Okey; G P Bondy; M E Mason; G F Kahl; H J Eisen; T M Guenthner; D W Nebert
Journal:  J Biol Chem       Date:  1979-11-25       Impact factor: 5.157

7.  Characteristics of a microsomal cytochrome P-448-mediated reaction. Ethoxyresorufin O-de-ethylation.

Authors:  M D Burke; R A Prough; R T Mayer
Journal:  Drug Metab Dispos       Date:  1977 Jan-Feb       Impact factor: 3.922

8.  Studies on the mechanism of absorption and distribution of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the rat.

Authors:  M R Lakshmanan; B S Campbell; S J Chirtel; N Ekarohita; M Ezekiel
Journal:  J Pharmacol Exp Ther       Date:  1986-12       Impact factor: 4.030

9.  Structural gene products of the Ah locus. Transcriptional regulation of cytochrome P1-450 and P3-450 mRNA levels by 3-methylcholanthrene.

Authors:  F J Gonzalez; R H Tukey; D W Nebert
Journal:  Mol Pharmacol       Date:  1984-07       Impact factor: 4.436

10.  Studies on the mechanism of toxicity of the chlorinated dibenzo-p-dioxins.

Authors:  A Poland; E Glover
Journal:  Environ Health Perspect       Date:  1973-09       Impact factor: 9.031

View more
  24 in total

1.  Pharmacokinetics and biological activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin. 2. Pharmacokinetics in rats using a loading-dose/maintenance-dose regime with high doses.

Authors:  R Krowke; I Chahoud; I Baumann-Wilschke; D Neubert
Journal:  Arch Toxicol       Date:  1989       Impact factor: 5.153

Review 2.  Long-term carcinogenesis studies on 2,3,7,8-tetrachlorodibenzo-p-dioxin and hexachlorodibenzo-p-dioxins.

Authors:  J E Huff; A G Salmon; N K Hooper; L Zeise
Journal:  Cell Biol Toxicol       Date:  1991-01       Impact factor: 6.691

3.  Polyhalogenated dibenzo-p-dioxins and dibenzofurans and the immune system. 1. Effects on peripheral lymphocyte subpopulations of a non-human primate (Callithrix jacchus) after treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).

Authors:  R Neubert; U Jacob-Müller; R Stahlmann; H Helge; D Neubert
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

4.  Pharmacokinetic model for the disposition of 3-methylcholanthrene in channel catfish after slow intraaortic infusion.

Authors:  S Choudhury; A H Karara; L N Ace
Journal:  Bull Environ Contam Toxicol       Date:  1993-12       Impact factor: 2.151

5.  Toxicokinetic interactions between chlorinated aromatic hydrocarbons in the liver of the C57BL/6J mouse: I. Polychlorinated biphenyls (PCBs).

Authors:  J de Jongh; F Wondergem; W Seinen; M Van den Berg
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

6.  Four generation reproductive toxicity study with 2,3,7,8-tetrachlorodibenzo-P-dioxin (TCDD) in rats. I. Toxicokinetic variations in dams and offspring.

Authors:  E Koch; E Thiel; E Chahoud; D Neubert
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

7.  Peri- and postnatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin: effects on physiological development, reflexes, locomotor activity and learning behaviour in Wistar rats.

Authors:  R Thiel; E Koch; B Ulbrich; I Chahoud
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

8.  Toxicogenomic evaluation of long-term hepatic effects of TCDD in immature, ovariectomized C57BL/6 mice.

Authors:  Anna K Kopec; Darrell R Boverhof; Rance Nault; Jack R Harkema; Colleen Tashiro; Dave Potter; Bonnie Sharratt; Brock Chittim; Timothy R Zacharewski
Journal:  Toxicol Sci       Date:  2013-07-17       Impact factor: 4.849

9.  Toxicokinetic mixture interactions between chlorinated aromatic hydrocarbons in the liver of the C57BL/6J mouse: 2. Polychlorinated dibenzo-p-dioxins (PCDDs), dibenzofurans (PCDFs) and biphenyls (PCBs).

Authors:  J De Jongh; R Nieboer; I Schröders; W Seinen; M Van den Berg
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

10.  Teratogenic potency of 2,3,4,7,8-pentachlorodibenzofuran and of three mixtures of polychlorinated dibenzo-p-dioxins and dibenzofurans in mice. Problems with risk assessment using TCDD toxic-equivalency factors.

Authors:  T Nagao; G Golor; H Hagenmaier; D Neubert
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.